Related Experiment Videos

Cytomegalovirus: genetics of drug resistance

¹Division of Virology, Glaxo Wellcome Co., Research Triangle Park, North Carolina, USA.

Advances in Experimental Medicine and Biology

|January 1, 1996

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Longitudinal observations on mutations conferring ganciclovir resistance in patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis: The Cytomegalovirus and Viral Resistance Study Group Report Number 8.

American journal of ophthalmology·2001

Inhibition of ganciclovir-susceptible and -resistant human cytomegalovirus clinical isolates by the benzimidazole L-riboside 1263W94.

Clinical and diagnostic laboratory immunology·2001

Differences in DNA packaging genes and sensitivity to benzimidazole ribonucleosides between human cytomegalovirus strains AD169 and Towne.

Antiviral chemistry & chemotherapy·2001

Mutations conferring ganciclovir resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis.

The Journal of infectious diseases·2000

Phosphorylation of ganciclovir phosphonate by cellular GMP kinase determines the stereoselectivity of anti-human cytomegalovirus activity.

Nucleosides, nucleotides & nucleic acids·2000

Synthesis and evaluation of a series of 2'-deoxy analogues of the antiviral agent 5,6-dichloro-2-isopropylamino-1-(beta-L-ribofuranosyl)-1H-benzimidazole (1263W94).

Nucleosides, nucleotides & nucleic acids·2000

See all related articles